glp-1 drug news today Supporters say the program is intended to respond to soaring demand for drugs, as more patients look for help managing weight. https://www.wbng.com/2026/07/14/cms-expands-access-glp-1 -weight-loss-medications-with-new-medicare-bridge-program A wave of new #GLP1

Glucose-Dependent Insulinotropic Polypeptide Inhibits Cardiac Hypertrophy and Fibrosis in Diabetic Mice via Suppression of TGF-2

22 Eight obese women reported reduced hunger following subcutaneous injections of exenatide and it was related with an enhanced functional connectivity of the nucleus tractus solitarius with the thalamus and hypothalamus

[2] [10] The low risk of hypoglycaemia when used as monotherapy or with metformin is another important benefit, as the glucose-dependent mechanism of insulin secretion means these medicines do not typically cause dangerously low blood sugar levels

Mornigo R, Vidal J, Lacy AM, Delgado S, Casamitjana R, Gomis R

This is a safe, non-invasive first step for anyone curious about their current health status or looking for a clear baseline before starting any lifestyle or medical intervention

The Middle East & Africa are expected to grow at a notable rate in the foreseeable future